Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey

BACKGROUND: Durvalumab as maintenance treatment after platinum-based concurrent chemoradiotherapy (cCRT) has become the standard of care in inoperable stage III non-small cell lung cancer (NSCLC). In this nationwide survey, we solicited members of the German Radiation Oncology Society to review the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Lung Cancer Res
Main Authors: Käsmann, Lukas, Eze, Chukwuka, Taugner, Julian, Roengvoraphoj, Olarn, Belka, Claus, Manapov, Farkhad
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225149/
https://ncbi.nlm.nih.gov/pubmed/32420068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.03.25
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares